Liposome Bupivacaine Interscalene Total Shoulder
common.study.values.description
“Liposome Bupivacaine Interscalene Total Shoulder”
This is a randomized prospective outcomes study comparing two groups of patients. One group will receive liposomal bupivacaine plus bupivacaine and the other will receive bupivacaine alone in interscalene blocks when undergoing total shoulder arthroplasty. The purpose of the study is to determine if LB plus bupivacaine provides superior pain control compared to bupivacaine alone when injected in an interscalene block for patients undergoing total shoulder arthroplasty surgery.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - liposome bupivacaine
interscalene block with liposomal bupivacaine plus bupivacaine
Drug - Bupivacaine
interscalene block with bupivacaine
participant.views.study.view.additional
participant.views.study.view.scientific-title
Prospective Randomized Controlled Trial Comparing Liposomal Bupivacaine to Bupivacaine Interscalene Blocks for Total Shoulder Arthroplasty Surgery; a Pilot Study
common.study.values.clinical-trial-id
NCT03587636
participant.views.study.view.id
en557d
